Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Healthtrust
Chubb
Citi
Fuji
UBS
Cantor Fitzgerald
Queensland Health
Teva

Generated: December 12, 2018

DrugPatentWatch Database Preview

PRASUGREL Drug Profile

« Back to Dashboard

Which patents cover Prasugrel, and when can generic versions of Prasugrel launch?

Prasugrel is a drug marketed by Accord Hlthcare, Amneal Pharms, Aurobindo Pharma Ltd, Mylan Pharms Inc, Panacea Biotec Ltd, and Uspharma Windlas. and is included in six NDAs.

The generic ingredient in PRASUGREL is prasugrel hydrochloride. There are nineteen drug master file entries for this compound. Eight suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the prasugrel hydrochloride profile page.

Drug patent expirations by year for PRASUGREL
Pharmacology for PRASUGREL
Medical Subject Heading (MeSH) Categories for PRASUGREL
Synonyms for PRASUGREL
[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxo-ethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate hydrochloride
[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate;hydrochloride
2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone Hydrochloride
2-Acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride
389574-19-0
5-((1RS)-2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridin-2-yl acetate hydrochloride
5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate hydrochloride
574C190
AB0009955
AC-24004
ACM389574190
AK124410
AKOS022185568
AM20090719
AN-6869
CAS-389574-19-0
CHEMBL1201773
CP0133
CS-1785
CTK8E7134
D05597
DSSTox_CID_28993
DSSTox_GSID_49067
DSSTox_RID_83258
DTXSID1049067
EBD36213
Effient (TN)
Ethanone, 2-(2-(acetyloxy)-6,7-dihydrothieno(3,2-c)pyridin-5(4H)-yl)-1-cyclopropyl-2-(2-fluorophenyl)-, hydrochloride
Ethanone, 2-[2-(acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)-, hydrochloride (1:1)
FT-0656362
HY-15284A
JALHGCPDPSNJNY-UHFFFAOYSA-N
LY 640315
MFCD11867705
MolPort-006-170-137
NCGC00188690-01
NCGC00188690-02
Prasugrel (hydrochloride)
Prasugrel HCl
Prasugrel hydrochloride
Prasugrel hydrochloride (JAN/USAN)
Prasugrel Hydrochloride [USAN]
Prasugrel Hydrochloride(Discontinued)
Prasugren hydrochloride
PubChem23807
RT-015128
s4637
SC-20618
SCHEMBL246128
Tox21_113621
Tox21_113621_1

US Patents and Regulatory Information for PRASUGREL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare PRASUGREL prasugrel hydrochloride TABLET;ORAL 205987-001 Feb 2, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc PRASUGREL prasugrel hydrochloride TABLET;ORAL 205927-001 Jul 12, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amneal Pharms PRASUGREL prasugrel hydrochloride TABLET;ORAL 205913-002 Jun 19, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Uspharma Windlas PRASUGREL prasugrel hydrochloride TABLET;ORAL 205790-002 Oct 16, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
US Army
Julphar
Cipla
US Department of Justice
Fish and Richardson
Chinese Patent Office
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.